PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.
http://ww2.peerview.com
Gesamtlänge aller Episoden: 45 days 20 hours 54 minutes
Dimitrios P. Kontoyiannis, MD, MS, ScD, FACP, FIDSA - Antifungal Pharmacology: Practical Considerations to Maximize Therapeutic Benefit and Tolerability
Go online to www.peerviewpress.com/h/r339 to view the entire programme with slides.
Robert Z. Orlowski, MD, PhD - Assessing the State of Established and Emerging Therapy in Relapsed/Refractory Myeloma
Go online to www.peerviewpress.com/h/r327 to view the entire programme with slides.
Ruben A. Mesa, MD, FACP - The Present and Future of Polycythemia Vera: Interdisciplinary Approaches to Patient-Centered Care
Go online to www.peerviewpress.com/h/e144 to view the entire programme with slides.
J. Sloan Manning, MD - Major Depressive Episodes Associated With Bipolar Disorder: How Can Diagnosis and Management Be Improved in the Primary Care Setting?
Go online to www.peerviewpress.com/h/d33 to view the entire programme with slides.
Sagar Lonial, MD - Patient-Focused Care in Multiple Myeloma: Ensuring Efficacy, Safety, and Optimal Treatment Selection
Go online to www.peerviewpress.com/h/d34 to view the entire programme with slides.
Edward B. Garon, MD, MS - Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice
Go online to www.peerview.com/CVU860 to view the entire programme with slides.
Amir T. Fathi, MD - The Oncologist, Nurse, and Patient Partnership in AML: Multiple Perspectives on Integrating Targeted Therapy Into Care
Go online to www.peerview.com/UMC860 to view the entire programme with slides.
Roy H. Decker, MD, PhD - The Era of Immunotherapy in Stage III NSCLC: Exploring the Evidence and Practicalities of Integrating Checkpoint Inhibition Into the Multimodal Treatment Arsenal
Go online to www.peerview.com/JXJ860 to view the entire programme with slides.
Anjali Saqi, MD, MBA and Geoffrey R. Oxnard, MD - Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists
Go online to www.peerview.com/VEV860 to view the entire programme with slides.
Lynette M. Sholl, MD - Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and New Guidelines: What Pathologists Need to Know and Do
Go online to www.peerview.com/TPF860 to view the entire programme with slides.